EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding DNA Damage Response and DNA Repair in Multiple Myeloma

Cole Petrilla, Joshua Galloway, Ruchi Kudalkar, Aya Ismael, Francesca Cottini iD

Cancers · 17.08.2023 · 15 (16) · 4155

DOI: 10.3390/cancers15164155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.08.2023. Verfasst von Cole Petrilla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Multiple Myeloma Research Foundation, Elsa U. Pardee Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a plasma cell malignancy characterized by several genetic abnormalities, including chromosomal translocations, genomic deletions and gains, and point mutations. DNA damage response (DDR) and DNA repair mechanisms are altered in MM to allow for tumor development, progression, and resistance to therapies. Damaged DNA rarely induces an apoptotic response, given the presence of ataxia-telangiectasia mutated (ATM) loss-of-function or mutations, as well as deletions, mutations, or downregulation of tumor protein p53 (TP53) and tumor protein p73 (TP73). Moreover, DNA repair mechanisms are either hyperactive or defective to allow for rapid correction of the damage or permissive survival. Medications used to treat patients with MM can induce DNA damage, by either direct effects (mono-adducts induced by melphalan), or as a result of reactive oxygen species (ROS) production by proteasome inhibitors such as bortezomib. In this review, we will describe the mechanisms of DDR and DNA repair in normal tissues, the contribution of these pathways to MM disease progression and other phenotypes, and the potential therapeutic opportunities for patients with MM.

Schlagwörter

Stichwörter der Autor:innen

DNA damage responseDNA repairmultiple myeloma

Autor:innen und Institutionen

  • Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.

ORCID-Profile: Francesca Cottini

Förderung

  • NCI NIH HHS
  • Multiple Myeloma Research Foundation
  • Elsa U. Pardee Foundation
  • International Myeloma Society
  • Paula and Rodger Riney Foundation Translational Research Award
  • Pelotonia Foundation
  • National Cancer Institute

Zitieren

APA

Petrilla, C., Galloway, J., Kudalkar, R., Ismael, A., & Cottini, F. (2023). Understanding DNA Damage Response and DNA Repair in Multiple Myeloma. Cancers, 15(16), 4155. https://doi.org/10.3390/cancers15164155

Vancouver

Petrilla C, Galloway J, Kudalkar R, Ismael A, Cottini F. Understanding DNA Damage Response and DNA Repair in Multiple Myeloma. Cancers. 2023;15(16):4155. doi:10.3390/cancers15164155

BibTeX
@article{Petrilla2023,
  author = {Petrilla, Cole and Galloway, Joshua and Kudalkar, Ruchi and Ismael, Aya and Cottini, Francesca},
  title = {Understanding DNA Damage Response and DNA Repair in Multiple Myeloma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {16},
  pages = {4155},
  doi = {10.3390/cancers15164155}
}
Kostenlos starten →